Daria-Faria Laboratories and Astra Component Indonesia (ASKI) have announced the launch of two new AI-based medical devices during a press conference held in the Indonesian capital, Jakarta. This innovation aims to enhance the autonomy of the national health industry and support preventive and promotional health programs in the country.
During the conference, the CEO of Daria-Faria, Dr. Ian Klore, emphasized that the development of two new devices, the DiViLab Optima and DiViLab Core, represents a strategic step towards providing technological solutions that support national health programs, especially in raising awareness and facilitating access to self-examinations.
Event Details
The DiViLab Optima device, which combines blood pressure measurement, blood sugar levels, cholesterol, and uric acid in one device, is the first multifunctional device of its kind in Indonesia. This device relies on AI and Internet of Things technologies, allowing users to monitor their health comprehensively and continuously.
On the other hand, the DiViLab Core provides a practical solution for accurately and efficiently testing blood sugar, cholesterol, and uric acid levels. Both devices aim to improve the quality of healthcare and facilitate access to medical services for citizens.
Background & Context
Indonesia, like many other countries, seeks to enhance its autonomy in the health industry, especially after the challenges posed by the COVID-19 pandemic. The Indonesian government has implemented multiple measures to boost local production of medical devices, contributing to increased reliance on domestic products.
Since ASKI began diversifying into the medical device sector, it has developed over 30 types of products, with the local content percentage in these products ranging from 40% to 59%. This reflects the local industry’s ability to compete with foreign products in terms of quality and technology.
Impact & Consequences
The launch of these devices represents an important step towards achieving Indonesia's goals of enhancing public health and reducing reliance on imports. By providing local solutions based on modern technology, Indonesia can improve the quality of healthcare and reduce costs associated with imports.
Moreover, these innovations may contribute to improving health awareness among citizens, leading to increased self-examinations and prevention of chronic diseases, thereby enhancing the overall quality of life.
Regional Significance
This initiative in Indonesia serves as a model for Arab countries seeking to enhance their autonomy in the health industry. Arab nations can benefit from Indonesian experiences in developing local solutions based on modern technology, contributing to improved healthcare standards and reduced reliance on imports.
In conclusion, innovation in the field of medical devices is a significant step towards achieving health independence and reflects the commitment of Indonesian companies to provide technological solutions that meet community needs.